| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.18 | 6e-07 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.2 | 4e-06 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | -0.17 | 6e-06 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.16 | 2e-05 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.15 | 6e-05 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.14 | 6e-05 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0001 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0001 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.29 | 0.0002 |